Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system

Molecular Therapy

Volumn 2, Issue 3, 2000, Pages 276-287

  Abruzzese, Ronald V ^a   Godin, Debra ^a   Mehta, Vidya ^a   Perrard, Jerry L ^a   French, Martha ^a   Nelson, Wendy ^a   Howell, Gaylen ^a   Coleman, Michael ^a   O'Malley, Bert W ^b   Nordstrom, Jeffrey L ^a  

^a Urigen Pharmaceuticals Inc   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autoinducible; Erythropoietin; Gene therapy; GeneSwitch; Mifepristone; Nonviral; Regulation; VEGF

Indexed keywords

CUCUMBER MOSAIC VIRUS;

ENDOTHELIAL CELL GROWTH FACTOR; ERYTHROPOIETIN; LIGAND; LYMPHOKINE; MIFEPRISTONE; PRIMER DNA; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PLASMID; PROMOTER REGION; SKELETAL MUSCLE;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; LYMPHOKINES; MICE; MICE, INBRED C57BL; MIFEPRISTONE; MUSCLE, SKELETAL; PLASMIDS; PROMOTER REGIONS (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034266617     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0115     Document Type: Article

References (40)

1. Vegeto, E., Allan, G. F., Schrader, W. T., Tsai, M. J., McDonnell, D. P., and O'Malley, B. W. (1 992). The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69: 703-713.
2. Abruzzese, R. V., et al. (1999). Ligand-dependent regulation of plasmid-based transgene expression in vivo. Hum. Gene Ther. 10: 1499-1507.
3. Burcin, M. M., Schiedner, G., Kochanek, S., Tsai, S. Y., and O'Malley, B. W. (1999). Adenovirus-mediated regulatable target gene expression in vivo. Proc. Natl. Acad. Sci. USA 96: 355-360.
4. Wang, Y., O'Malley, B. W., Jr., Tsai, S. Y., and O'Malley, B. W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91: 8180-8184.
5. Wang, Y., Xu, J., Pierson, T., O'Malley, B. W., and Tsai, S. Y. (1997). Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator. Gene Ther. 4: 432-441.
6. Oligino, T., et al. (1998). Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther. 5: 491-496.
7. Wang, X-J., Liefer, K. M., Tsai, S., O'Malley, B. W., and Roop, D. R. (1999). Development of gene-switch transgenic mice that inducibly express transforming growth factor β1 in the epidermis. Proc. Natl. Acad. Sci. USA 96: 8483-8488.
8. Wang, Y. F., DeMayo, J., Tsai, S. Y., and O'Malley, B. W. (1997). Ligand-inducible and liver specific target gene expression in transgenic mice. Nat. Biotechnol. 15: 239-243.
9. Ptashne, M., et al. (1980). How the I repressor and cro work. Cell 19: 1-11.
10. Schlief, R. (1987). The L-arabinose operon, in Escherichia coli and Salmonella typhimurium. In Cellular and Molecular Biology (F. C. Neidhardt, Ed.), Vol. 2, pp. 1473-1481. Am. Soc. Microbiol., Washington, DC.
11. Holland, P. M., Abramson, R. D., Watson, R., and Gelfand, D. H. (1991). Detection of specific polymerase chain reaction products by utilizing the 5′ ◆ 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 8: 7276-7280.
12. Livak, K. J., Flood, J. A., Marmaro, J., Giusti, W., and Deetz, K. (1995). Oligonucleotide with fluorescent dyes at opposite ends provides a quenched probe system useful for detecting PCR product and nucleic acid hybridization. In PCR Methods and Applications, pp. 357-362. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. Blezinger, P., et al. (1999). Intratracheal administration of interleukin-12 plasmid-cationic lipid complexes inhibits murine lung metastases. Hum. Gene Ther. 10: 723-731.
14. Nordstrom, J. L. (1999). Expression plasmids for non-viral gene therapy. In Advanced Gene Delivery: From Concepts to Pharmaceutical Products (A. Rolland, Ed.), pp. 15-43. Harwood Academic Publishers GMBH, Amsterdam, The Netherlands.
15. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547-5551.
16. Gallia, G. L., and Khalili, K. (1998). Evaluation of an autoregulatory tetracycline regulated system. Oncogene 16: 1879-1884.
17. Haberman, R. P., McCown, T. J., and Samulski, R. J. (1998). Inducible long-term expression in brain with adeno-associated virus gene transfer. Gene Ther. 5: 1604-1611.
18. Mohammadi, S. A., and Hawkins, R. E. (1998). Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 5: 76-84.
19. Shockett, P., Difilippantonio, M., Hellman, N., and Schatz, D. G. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92: 6522-6526.
20. Hofmann, A., Nolan G. P., and Blau, H. M. (1996). Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93: 5185-5190.
21. Liang, X., Hartikka, J., Sukhu, L., Manthorpe, M., and Hobart, P. (1996). Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3: 350-356.
22. Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., and Blau, H. M. (1998). VEGF gene delivery to muscle: Potential role for vasculogenesis in adults. Mol. Cell 2: 549-558.
23. Benjamin, L. E., and Keshet, E. (1997). Conditional switching of VEGF expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94: 8761-8766.
24. Yoshiji, H., et al. (1998). Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells. Hepatology 6: 1489-1496.
25. Yoshiji, H., Harris, S. R., and Thorgeirsson, U. P. (1997). Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 57(18): 3924-3928.
26. Losordo, D. W., Vale, P. R., and Isner, J. M. (1999). Gene therapy for myocardial angiogenesis. Am. Heart J. 138: 132-141.
27. Symes, J. F., et al. (1999). Gene therapy with VEGF for inoperable coronary artery disease. Ann. Thorac. Surg. 68: 830-836.
28. Tio, R. A., et al. (1999). Intramyocardial gene therapy with naked DNA encoding VEGF improves collateral flow to ischemic myocardium. Hum. Gene Ther. 10: 2953-2960.
29. 165 in patient with ischaemic limb. Lancet 348: 370-373.
30. Wolff, J. A., Ludtke, J. J., Ascadi, G., Williams, P., and Jani, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1: 363-369.
31. Tripathy, S. K., et al. (1996). Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA 93: 10876-10880.
32. Bohl, D., Salvetti, A., Moullier, P., and Heard, J. M. (1998). Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92: 1512-1517.
33. Rendahl, K. G., et al. (1998). Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat. Biotechnol. 16: 757-761.
34. Rizzuto, G., et al. (1999). Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. USA 96: 6417-6422.
35. Ye, X., et al. (1999). Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283: 88-91.
36. Felgner, P. L., Zelphati, O., and Liang, X. (1999). Advances in synthetic gene-delivery system technology. In The Development of Human Gene Therapy (T. Friedmann, Ed.), pp. 241-260. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Aihara, H., and Miyazaki, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16: 867-870.
38. Mathiesen, I. (1999). Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6: 508-514.
39. Mir, L. M., et al. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96: 4262-4267.
40. Mumper, R. J., et al. (1998). Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle. J. Controlled Release 52: 191-203.